Graphite Bio, Inc. / Fundamentals
Income statement
- Net revenue
-€4.51M - Cost of goods sold
€811.58K - Gross profit
-€8.01M - SG&A expenses
€28.34M - R&D expenses
€32.92M - EBITDA
-€3.04M - D&A
-€783.15K - EBIT
-€42.76M - Interest expenses
€0.00 - EBT
-€23.23M - Tax expenses
€27.86M - Net income
-€23.66M
Cash flow statement
- Net deferred tax
€66.09M - Non-cash items
-€116.49M - Changes in working capital
€70.78M - Operating cash flow
€10.14M - Capex
-€3.25M - Other investing cash flow
-€765.06K - Net investing cash flow
-€407.22M - Total cash dividends paid
€0.00 - Issuance of common stock
€67.42M - Debt repayment
€0.00 - Other financing cash flow
€25.51M - Net financing cash flow
€70.48M - Foreign exchange effects
-€141.31M - Net change in cash
-€277.47M - Cash at end of period
€32.50M - Free cash flow
€6.89M
Balance sheet
- Cash and cash equivalents
€32.40M - Cash and short-term investments
€180.51M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.52M - Total current assets
€184.03M - Property, plant & equipment
€1.83M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€1.38M - Total non-current assets
€3.21M - Total assets
€187.24M - Accounts payable
€2.46M - Short-term debt
€0.00 - Other current liabilities
€6.50M - Total current liabilities
€8.96M - Long-term debt
€490.22K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€490.22K - Total liabilities
€9.45M - Common stock
€861.55 - Retained earnings
-€150.38M - Other equity
€32.74K - Total equity
€177.79M - Total liabilities and shareholders' equity
€187.24M
Company information
- Market capitalization
€157.96M - Employees
6 - Enterprise Value
€822.53M
Company ratios
- Gross margin
-
177.5% Much better than peer group: -2,496,469,139,154.3% - EBITDA margin
-
67.3% Much better than peer group: -5,905,399,072,530.4% - EBIT margin
-
947.8% Much better than peer group: -6,244,714,350,108.2% - EBT margin
-
515.0% Much better than peer group: -5,992,523,024,912.7% - Net margin
-
524.5% Much better than peer group: -5,992,523,027,438.7% - ROE
-
-13.3% Much better than peer group: -87.2% - ROA
-
-12.6% Much better than peer group: -49.5% - Asset turnover
-
-2.4% Much better than peer group: -1,468.3% - FCF margin
-
-296.9% Much better than peer group: -4,992,391,094,356.4% - FCF yield
8.5% - Efficiency ratio
32.7% - Net sales per employee
-
-€751.85K - Net income per employee
-
-€3.94M